Eton Pharmaceuticals, Inc. (ETON)
50.19
+0.97
(+1.97%)
USD |
NASDAQ |
Oct 20, 16:00
50.96
+0.77
(+1.53%)
After-Hours: 04:45
Eton Pharmaceuticals Price to Book Value : 30.48 for Oct. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 20, 2026 | 30.48 |
| October 19, 2026 | 29.89 |
| October 16, 2026 | 30.55 |
| October 15, 2026 | 31.17 |
| October 14, 2026 | 32.11 |
| October 13, 2026 | 32.39 |
| October 12, 2026 | 33.55 |
| October 09, 2026 | 33.53 |
| October 08, 2026 | 33.25 |
| October 07, 2026 | 33.33 |
| October 06, 2026 | 33.26 |
| October 05, 2026 | 33.78 |
| October 02, 2026 | 33.62 |
| October 01, 2026 | 31.57 |
| September 30, 2026 | 31.27 |
| September 29, 2026 | 35.94 |
| September 28, 2026 | 35.94 |
| September 25, 2026 | 35.03 |
| September 24, 2026 | 36.13 |
| September 23, 2026 | 33.77 |
| September 22, 2026 | 34.67 |
| September 21, 2026 | 33.59 |
| September 18, 2026 | 33.70 |
| September 17, 2026 | 34.66 |
| September 16, 2026 | 34.22 |
| Date | Value |
|---|---|
| September 15, 2026 | 33.36 |
| September 14, 2026 | 34.99 |
| September 11, 2026 | 34.66 |
| September 10, 2026 | 35.15 |
| September 09, 2026 | 35.73 |
| September 08, 2026 | 36.04 |
| September 04, 2026 | 35.50 |
| September 03, 2026 | 36.38 |
| September 02, 2026 | 37.63 |
| September 01, 2026 | 36.70 |
| August 31, 2026 | 36.70 |
| August 28, 2026 | 36.30 |
| August 27, 2026 | 38.06 |
| August 26, 2026 | 38.03 |
| August 25, 2026 | 38.29 |
| August 24, 2026 | 39.13 |
| August 21, 2026 | 38.54 |
| August 20, 2026 | 36.38 |
| August 19, 2026 | 37.34 |
| August 18, 2026 | 38.52 |
| August 17, 2026 | 37.49 |
| August 14, 2026 | 35.74 |
| August 13, 2026 | 24.78 |
| August 12, 2026 | 25.25 |
| August 11, 2026 | 25.54 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Aquestive Therapeutics, Inc. | -- |
| Pfizer Inc. | 2.014 |
| Elite Pharmaceuticals, Inc. | 2.52 |
| Daré Bioscience, Inc. | -- |
| Liquidia Corp. | 16.60 |
Price to Book Value Related Metrics
| PE Ratio | 132.67 |
| PS Ratio | 14.55 |
| Price | 50.19 |
| Earnings Yield | 0.75% |
| Market Cap | 1.420B |
| Operating PE Ratio | 93.10 |
| Normalized PE Ratio | 130.94 |